• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

入院 B 型利钠肽水平可预测低危 ST 段抬高型心肌梗死患者的长期生存。

Admission B-type natriuretic peptide level predicts long-term survival in low risk ST-elevation myocardial infarction patients.

机构信息

Department of Cardiology, Medical University of Bialystok, Bialystok, Poland.

出版信息

Kardiol Pol. 2011;69(10):1008-14.

PMID:22006598
Abstract

BACKGROUND

In patients with acute myocardial infarction (AMI), B-type natriuretic peptide (BNP) is a predictor of short- and medium-term mortality.

AIM

To evaluate the long-term prognostic value of a single measurement of plasma BNP in low risk patients with first ST-elevation myocardial infarction (STEMI).

METHODS

Plasma BNP concentrations were analysed on admission in 211 patients, median age 68 (56.0-75.0) years, admitted with first STEMI and treated with primary percutaneous coronary intervention (PPCI). Left ventricular ejection fraction (LVEF) was assessed by echocardiography during the first 24 h. Patients were followed for a median 48.2 (42.3-72.6) months.

RESULTS

The median BNP level was 92.5 (36.3-199.2) pg/mL. During the follow-up period, 79.6% of patients survived. Logistic regression analysis indicated that among the assessed clinical, biochemical, angiographic and echocardiographic parameters, the best predictors of mortality were age, LVEF, maximal creatinine concentration and BNP measurements, (p < 0.05). In multivariate Cox regression analysis for the prediction of death, only age remained significant (p = 0.00007). Admission BNP level > 400 pg/mL indicated patients with the highest risk of death (47.1% vs 22% and 18.4% in patients with BNP level < 100 pg/mL and 100-400 pg/mL, respectively; p < 0.05).

CONCLUSIONS

A single measurement of BNP on admission can improve long-term risk stratification in low risk first STEMI patients treated with PPCI.

摘要

背景

在急性心肌梗死(AMI)患者中,B 型利钠肽(BNP)是短期和中期死亡率的预测指标。

目的

评估初次 ST 段抬高型心肌梗死(STEMI)低危患者单次测量血浆 BNP 的长期预后价值。

方法

对 211 例初次接受经皮冠状动脉介入治疗(PPCI)的初次 STEMI 患者入院时的血浆 BNP 浓度进行分析,中位年龄 68(56.0-75.0)岁。在首次 24 小时内行超声心动图评估左心室射血分数(LVEF)。中位随访时间为 48.2(42.3-72.6)个月。

结果

中位 BNP 水平为 92.5(36.3-199.2)pg/ml。在随访期间,79.6%的患者存活。Logistic 回归分析表明,在所评估的临床、生化、血管造影和超声心动图参数中,死亡率的最佳预测因素是年龄、LVEF、最大肌酐浓度和 BNP 测量值(p < 0.05)。多变量 Cox 回归分析预测死亡,只有年龄具有统计学意义(p = 0.00007)。入院时 BNP 水平 > 400pg/ml 表明患者死亡风险最高(47.1%比 BNP 水平 < 100pg/ml 和 100-400pg/ml 的患者分别为 22%和 18.4%;p < 0.05)。

结论

在接受 PPCI 治疗的初次 STEMI 低危患者中,单次入院 BNP 测量可改善长期风险分层。

相似文献

1
Admission B-type natriuretic peptide level predicts long-term survival in low risk ST-elevation myocardial infarction patients.入院 B 型利钠肽水平可预测低危 ST 段抬高型心肌梗死患者的长期生存。
Kardiol Pol. 2011;69(10):1008-14.
2
Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.血浆B型利钠肽水平可预测急性ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时的心肌组织灌注情况。
Coron Artery Dis. 2011;22(6):405-10. doi: 10.1097/MCA.0b013e3283487dac.
3
Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty.入院时的血清B型利钠肽水平不仅可预测急性ST段抬高型心肌梗死患者接受直接经皮冠状动脉腔内血管成形术治疗后的短期死亡情况,还能预测手术的血管造影成功率。
Am Heart J. 2004 Oct;148(4):655-62. doi: 10.1016/j.ahj.2004.04.023.
4
Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.入院时B型利钠肽评估可改善接受直接经皮冠状动脉腔内血管成形术治疗的急性ST段抬高型心肌梗死患者按Killip分级和心肌梗死溶栓治疗(TIMI)风险评分进行的早期风险分层。
Int J Cardiol. 2007 Feb 14;115(3):386-90. doi: 10.1016/j.ijcard.2006.04.038. Epub 2006 Jul 24.
5
Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.比较 N 端脑利钠肽前体作为独立预测因子在接受直接经皮冠状动脉介入治疗的前壁与非前壁 ST 段抬高型心肌梗死患者入院时心脏血清生物标志物中对心功能的预测价值。
Am J Cardiol. 2010 Apr 15;105(8):1065-9. doi: 10.1016/j.amjcard.2009.12.003. Epub 2010 Feb 20.
6
B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.ST段抬高型心肌梗死患者就诊时的B型利钠肽与预后:ENTIRE-TIMI-23亚研究
J Am Coll Cardiol. 2004 Jul 21;44(2):335-9. doi: 10.1016/j.jacc.2004.04.033.
7
Occurrence and predictors of left ventricular systolic dysfunction at hospital discharge and in long-term follow-up after acute myocardial infarction treated with primary percutaneous coronary intervention.急性心肌梗死后行直接经皮冠状动脉介入治疗患者出院时及长期随访中心脏左室收缩功能障碍的发生及预测因素。
Kardiol Pol. 2012;70(4):329-40.
8
Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score.首次ST段抬高型心肌梗死患者入院时血浆B型利钠肽测定与C反应蛋白及TIMI风险评分相比的预后意义
Clin Chim Acta. 2007 Jul;382(1-2):106-11. doi: 10.1016/j.cca.2007.04.002. Epub 2007 Apr 12.
9
Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.入院时的血清 B 型利钠肽可预测 ST 段抬高型心肌梗死患者行直接药物洗脱支架置入术后的“无复流”现象。
Int J Cardiol. 2010 May 28;141(2):175-81. doi: 10.1016/j.ijcard.2008.11.189. Epub 2009 Jan 13.
10
Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.ST段抬高型心肌梗死入院时血浆脑钠肽水平与6个月后通过超声心动图和心脏磁共振测量的左心室舒张末期容积的关系。
Am J Cardiol. 2009 Oct 1;104(7):878-82. doi: 10.1016/j.amjcard.2009.05.025.